Wednesday, July 8, 2026

Patent intelligence · US

US 7086862

Tooth bleaching process

granted A61KA61K2800/81A61K2800/88A61K8/22
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 0
Applicant portfolio 706
Patent details — US 7086862
Jurisdiction
US
Status
granted
Grant date
Aug 8, 2006
Expiration
Aug 3, 2026
Applicant
DISCUS DENTAL, LLC
Claims
34
CPC classes
A61K, A61K2800/81, A61K2800/88, A61K8/22
View on Google Patents ↗

Quick answer

US 7086862 (Tooth bleaching process) is held by DISCUS DENTAL, LLC. Status: granted. Granted Aug 8, 2006. Expires Aug 3, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
DISCUS DENTAL, LLC
Grant date
Expiration
Claims
34
CPC classes
A61K, A61K2800/81, A61K2800/88, A61K8/22

More from DISCUS DENTAL, LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12427173

    Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies

    Biomed Valley Discoveries, Inc. · Expires Sep 25, 2045

    granted
  2. US 12428415

    Matriptase 2 inhibitors and uses thereof

    Disc Medicine, Inc. · Expires Sep 25, 2045

    granted
  3. US 12421236

    Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

    Medshine Discovery Inc. · Expires Sep 18, 2045

    granted
  4. US 12420085

    Synergistic therapies for inter vertebral disc degeneration

    Discure Technologies Ltd · Expires Sep 18, 2045

    granted
  5. US 12421231

    Azaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Expires Sep 18, 2045

    granted
  6. US 12403069

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Expires Aug 28, 2045

    granted
  7. US 12398179

    Nanomolar peptides and derivatives to differentially modulate ephrin receptors

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Expires Aug 21, 2045

    granted
  8. US 12396924

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Expires Aug 21, 2045

    granted

Frequently asked questions

What is US patent 7086862?

US 7086862 (Tooth bleaching process) is held by DISCUS DENTAL, LLC. Status: granted. Granted Aug 8, 2006. Expires Aug 3, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7086862?

DISCUS DENTAL, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.

When does US 7086862 expire?

Our index shows an expiration date of Aug 3, 2026 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.